In this technote, we introduce the AI‑driven, plate‑based VCD assessment on the UP.SIGHT™ 2nd Gen, combining high‑resolution bottom‑well imaging with YOYO‑1‑based viability staining and automated reporting in C.STUDIO. The method delivers linear, reproducible VCD measurements across a broad dynamic range and integrates seamlessly into automated CLD workflows.
Learn more about how:
- AI‑powered VCD on UP.SIGHT™ 2nd Gen provides linear, reproducible measurements across a 3‑log dynamic range using YOYO‑1 viability staining.
- Bottom‑well imaging and automated cell detection eliminate variability, operator bias, and limitations of manual or indirect VCD methods.
- C.STUDIO centralizes VCD, titer, monoclonality proof, and growth‑tracking images, streamlining clone‑picking decisions and removing CLD data silos.